Colgate-Palmolive (CL) insider plans 161,021-share cashless option sale

Rhea-AI Filing Summary

Colgate-Palmolive Co insider Noel Wallace filed a notice to potentially sell 161,021 shares of common stock through Merrill Lynch on August 5, 2026 on the NYSE. The shares relate to an exercise of employee stock options via a broker-assisted cashless exercise. The filing also lists a sale during the prior three months of 161,021 shares of common stock on August 4, 2026, with an aggregate value of $14,800,720.47.

Key Figures

Shares proposed for sale: 161,021 shares Proposed sale value: $14,897,912.14 Past 3 months sale shares: 161,021 shares +2 more

5 metrics

Shares proposed for sale 161,021 shares Common stock covered by notice for 08/05/2026 sale

Proposed sale value $14,897,912.14 Approximate aggregate market value of 161,021 shares

Past 3 months sale shares 161,021 shares Common stock sold on 08/04/2026

Past 3 months sale value $14,800,720.47 Aggregate value of shares sold on 08/04/2026

Transaction date (proposed sale) 08/05/2026 Date for proposed NYSE sale via Merrill Lynch

Key Terms

Form 144, employee stock options, broker assisted cashless exercise

3 terms

Form 144 regulatory

"144: Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

employee stock options financial

"Exercise of employee stock options | COLGATE PALMOLIVE CO"

Employee stock options are contracts that give workers the right to buy a company's shares at a set price sometime in the future, like a coupon that lets you purchase stock at today’s price later on. Investors care because they align employees’ incentives with company performance and create a potential future claim on shares that can reduce existing owners’ percentage and add to a company’s reported compensation costs.

broker assisted cashless exercise financial

"161021 | 08/05/2026 | Broker assisted cashless exercise"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/05/2026 - 04:11 PM Accepted by SEC EDGAR 08/05/2026 - 04:10 PM Learn about SEC filing dates

FAQ

What stock transaction did Colgate-Palmolive (CL) insider Noel Wallace report?

Noel Wallace reported a potential sale of 161,021 shares of Colgate-Palmolive common stock, related to an exercise of employee stock options to be executed via a broker-assisted cashless exercise on August 5, 2026 through Merrill Lynch on the NYSE.

How many Colgate-Palmolive (CL) shares are covered by this Form 144 filing?

The filing covers up to 161,021 shares of Colgate-Palmolive common stock. These shares are tied to an exercise of employee stock options and are planned to be sold through a broker-assisted cashless exercise on August 5, 2026.

What is the approximate market value of the Colgate-Palmolive (CL) shares in the planned sale?

The Form 144 lists an approximate aggregate market value of $14,897,912.14 for the 161,021 shares of Colgate-Palmolive common stock proposed for sale through Merrill Lynch on August 5, 2026 on the NYSE.

What prior Colgate-Palmolive (CL) stock sale is disclosed in the past 3 months section?

The filing discloses that on August 4, 2026, Noel Wallace sold 161,021 shares of Colgate-Palmolive common stock, with an aggregate value of $14,800,720.47, reported in the section covering securities sold during the past three months.

What method will be used to sell the Colgate-Palmolive (CL) shares in this notice?

The planned sale uses a broker-assisted cashless exercise tied to employee stock options. Merrill Lynch, located at 225 Liberty Street in New York, is listed as the broker for the proposed NYSE transaction on August 5, 2026.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 225 Liberty Street Floor 37 New York NY 10281	161021	14897912.14	797172829	08/05/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/05/2026	Exercise of employee stock options	COLGATE PALMOLIVE CO			161021	08/05/2026	Broker assisted cashless exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Noel Wallace 300 PARK AVE NEW YORK NY 10022	Common Stock	08/04/2026	161021	14800720.47

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)